TY - JOUR
T1 - Risk factors for 30-day hospital readmission after radical gastrectomy
T2 - a single-center retrospective study
AU - Asaoka, Raito
AU - Kawamura, Taiichi
AU - Makuuchi, Rie
AU - Irino, Tomoyuki
AU - Tanizawa, Yutaka
AU - Bando, Etsuro
AU - Terashima, Masanori
N1 - Funding Information:
Acknowledgements This work was supported in part by The National Cancer Center Research and Development Fund (29-A-3).
Publisher Copyright:
© 2018, The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
PY - 2019/3/15
Y1 - 2019/3/15
N2 - Background: Hospital readmission is gathering greater attention as a measure of health care quality. The introduction of fast-track surgery has led to shorter lengths of hospitalization without increasing the risk of postoperative complications and readmission. The collection of comprehensive readmission data is essential for the further improvement of patient care. The aim of the present study is to evaluate the risk factors for readmission within 30 days of discharge after gastrectomy. Methods: A total of 1929 patients who underwent radical gastrectomy at Shizuoka Cancer Center were included in this study. A risk analysis with a stepwise logistic regression model was conducted to identify the risk factors for 30-day hospital readmission. Results: The 30-day readmission rate was 2.70%. Common causes of readmission were an intolerance of oral intake and the presence of an intra-abdominal abscess. The C reactive protein (CRP) level on postoperative day (POD) 3 was significantly higher in the readmitted group; however, the other surgical outcomes, including the incidence of postoperative complications, did not differ to a statistically significant extent. The stepwise logistic regression analysis revealed that CRP on POD3 ≥ 12 mg/dl [odds ratio (OR) 2.08, 95% confidence interval (CI) 1.09–3.95, p = 0.025], laparoscopic surgery (OR 2.25, 95% CI 1.17–4.31, p = 0.015), and TG (OR 2.23, 95% CI 1.17–4.78, p = 0.023) were found to be independent risk factors for readmission. Conclusions: CRP on POD3 ≥ 12 mg/dl, laparoscopic surgery, and TG were identified as independent risk factors for readmission.
AB - Background: Hospital readmission is gathering greater attention as a measure of health care quality. The introduction of fast-track surgery has led to shorter lengths of hospitalization without increasing the risk of postoperative complications and readmission. The collection of comprehensive readmission data is essential for the further improvement of patient care. The aim of the present study is to evaluate the risk factors for readmission within 30 days of discharge after gastrectomy. Methods: A total of 1929 patients who underwent radical gastrectomy at Shizuoka Cancer Center were included in this study. A risk analysis with a stepwise logistic regression model was conducted to identify the risk factors for 30-day hospital readmission. Results: The 30-day readmission rate was 2.70%. Common causes of readmission were an intolerance of oral intake and the presence of an intra-abdominal abscess. The C reactive protein (CRP) level on postoperative day (POD) 3 was significantly higher in the readmitted group; however, the other surgical outcomes, including the incidence of postoperative complications, did not differ to a statistically significant extent. The stepwise logistic regression analysis revealed that CRP on POD3 ≥ 12 mg/dl [odds ratio (OR) 2.08, 95% confidence interval (CI) 1.09–3.95, p = 0.025], laparoscopic surgery (OR 2.25, 95% CI 1.17–4.31, p = 0.015), and TG (OR 2.23, 95% CI 1.17–4.78, p = 0.023) were found to be independent risk factors for readmission. Conclusions: CRP on POD3 ≥ 12 mg/dl, laparoscopic surgery, and TG were identified as independent risk factors for readmission.
KW - Gastric cancer
KW - Hospital readmission
KW - Radical gastrectomy
UR - http://www.scopus.com/inward/record.url?scp=85049829941&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049829941&partnerID=8YFLogxK
U2 - 10.1007/s10120-018-0856-4
DO - 10.1007/s10120-018-0856-4
M3 - Article
C2 - 30006830
AN - SCOPUS:85049829941
SN - 1436-3291
VL - 22
SP - 413
EP - 420
JO - Gastric Cancer
JF - Gastric Cancer
IS - 2
ER -